Department of Medicine, Albert Einstein College of Medicine, New York, New York (M.M.); Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy (M.B.); Gruppo Oncologico Ricercatori Italiani, GORI ONLUS, Pordenone, Italy (M.B.); Department of Biomedical and Biotechnological Sciences, University of Catania, Catania Italy (G.P.); Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, Italy (V.C.); and Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York (G.L.R.).
Department of Medicine, Albert Einstein College of Medicine, New York, New York (M.M.); Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy (M.B.); Gruppo Oncologico Ricercatori Italiani, GORI ONLUS, Pordenone, Italy (M.B.); Department of Biomedical and Biotechnological Sciences, University of Catania, Catania Italy (G.P.); Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, Italy (V.C.); and Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York (G.L.R.)
J Pharmacol Exp Ther. 2023 Jan;384(1):1-9. doi: 10.1124/jpet.122.001158. Epub 2022 Jun 6.
Argonautes (AGOs) are a highly conserved family of proteins found in most eukaryotes and involved in mechanisms of gene regulation, both at the transcriptional and post-transcriptional level. Among other functions, AGO proteins associate with microRNAs (miRNAs) to mediate the post-transcriptional repression of protein-coding genes. In this process, AGOs associate with members of the trinucleotide repeat containing 6 protein (TNRC6) family to form the core of the RNA-induced silencing complex (RISC), the effector machinery that mediates miRNA function. However, the description of the exact composition of the RISC has been a challenging task due to the fact the AGO's interactome is dynamically regulated in a cell type- and condition-specific manner. Here, we summarize some of the most significant studies that have identified AGO complexes in mammalian cells, as well as the approaches used to characterize them. Finally, we discuss possible opportunities to exploit what we have learned on the properties of the RISC to develop novel anti-cancer therapies. SIGNIFICANCE STATEMENT: The RNA-induced silencing complex (RISC) is the molecular machinery that mediates miRNA function in mammals. Studies over the past two decades have shed light on important biochemical and functional properties of this complex. However, many aspects of this complex await further elucidation, mostly due to technical limitations that have hindered full characterization. Here, we summarize some of the most significant studies on the mammalian RISC and discuss possible sources of biases in the approaches used to characterize it.
Argonautes (AGOs) 是一类在大多数真核生物中高度保守的蛋白家族,参与基因调控机制,包括转录和转录后水平。除了其他功能外,AGO 蛋白与 microRNAs (miRNAs) 结合,介导对蛋白质编码基因的转录后抑制。在这个过程中,AGO 与三核苷酸重复包含 6 蛋白 (TNRC6) 家族的成员结合,形成 RNA 诱导沉默复合物 (RISC) 的核心,该复合物是介导 miRNA 功能的效应机制。然而,由于 AGO 的相互作用组以细胞类型和条件特异性的方式动态调节,因此准确描述 RISC 的组成一直是一项具有挑战性的任务。在这里,我们总结了一些在哺乳动物细胞中鉴定 AGO 复合物的最重要的研究,以及用于表征它们的方法。最后,我们讨论了利用我们对 RISC 性质的了解开发新型抗癌疗法的可能机会。
RNA 诱导沉默复合物 (RISC) 是介导哺乳动物中 miRNA 功能的分子机制。过去二十年的研究揭示了该复合物的重要生化和功能特性。然而,该复合物的许多方面仍有待进一步阐明,主要是由于技术限制阻碍了其全面表征。在这里,我们总结了一些关于哺乳动物 RISC 的最重要的研究,并讨论了用于表征它的方法中可能存在的偏见来源。